Previous close | 22.33 |
Open | 24.50 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 24.50 - 24.50 |
52-week range | 21.28 - 27.15 |
Volume | |
Avg. volume | 108 |
Market cap | 5.562B |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 28.82 |
EPS (TTM) | 0.85 |
Earnings date | N/A |
Forward dividend & yield | 0.72 (2.92%) |
Ex-dividend date | 21 Mar 2024 |
1y target est | N/A |
Key Insights Significantly high institutional ownership implies Hikma Pharmaceuticals' stock price is sensitive to...
I want to increase my exposure to the pharmaceuticals industry this year, so I've been looking for undervalued stocks to buy with strong growth potential. The post I’m considering these 3 undervalued pharma stocks to buy for my portfolio in April appeared first on The Motley Fool UK.
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...